ATE361119T1 - Prävention und therapie von leberzirrhosen - Google Patents

Prävention und therapie von leberzirrhosen

Info

Publication number
ATE361119T1
ATE361119T1 AT99919561T AT99919561T ATE361119T1 AT E361119 T1 ATE361119 T1 AT E361119T1 AT 99919561 T AT99919561 T AT 99919561T AT 99919561 T AT99919561 T AT 99919561T AT E361119 T1 ATE361119 T1 AT E361119T1
Authority
AT
Austria
Prior art keywords
cirrhosis
liver
prevention
treatment
preventives
Prior art date
Application number
AT99919561T
Other languages
English (en)
Inventor
Yoshiyuki Ueno
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Application granted granted Critical
Publication of ATE361119T1 publication Critical patent/ATE361119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99919561T 1998-05-14 1999-05-13 Prävention und therapie von leberzirrhosen ATE361119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13177198 1998-05-14

Publications (1)

Publication Number Publication Date
ATE361119T1 true ATE361119T1 (de) 2007-05-15

Family

ID=15065784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99919561T ATE361119T1 (de) 1998-05-14 1999-05-13 Prävention und therapie von leberzirrhosen

Country Status (5)

Country Link
EP (1) EP1077069B1 (de)
AT (1) ATE361119T1 (de)
CA (1) CA2328601A1 (de)
DE (1) DE69935976D1 (de)
WO (1) WO1999058150A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3868374A3 (de) 2016-03-22 2021-11-10 Mayo Foundation for Medical Education and Research Verwendung von fettsäuresynthaseinhibitoren zur behandlung von fibrose

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08127594A (ja) * 1993-11-10 1996-05-21 Mochida Pharmaceut Co Ltd Ｆａｓ抗原に結合する新規蛋白質およびそれをコードするＤＮＡ
NZ311174A (en) * 1995-06-30 1999-04-29 Mochida Pharm Co Ltd Anti-fas ligand antibody which suppresses fas ligand-induced apoptosis in cells and method of assaying a fas ligand using the anti-fas ligand antibody
JPH0972901A (ja) * 1995-09-01 1997-03-18 Nippon Dpc Corp 肝疾患群の評価法
JPH09124509A (ja) * 1995-10-27 1997-05-13 Sumitomo Electric Ind Ltd 肝炎治療剤
US6306395B1 (en) * 1996-05-02 2001-10-23 Mochida Pharmaceutical Co., Ltd. Fas antigen derivatives

Also Published As

Publication number Publication date
CA2328601A1 (en) 1999-11-18
DE69935976D1 (de) 2007-06-14
WO1999058150A1 (en) 1999-11-18
EP1077069A4 (de) 2004-06-16
EP1077069B1 (de) 2007-05-02
EP1077069A1 (de) 2001-02-21

Similar Documents

Publication Publication Date Title
CY1110309T1 (el) Φαρμακευτικες συνθεσεις για την προληψη και την αγωγη διαταραχων του κεντρικου νευρικου συστηματος περιλαμβανοντας ενα αναλογο νικοτινης και εναν αναστολεα ακετυλχολινεστερασης
SE9901272D0 (sv) New improved formulation
DE69838099D1 (de) Quinazolinenon-enthaltende pharmazeutische zusammensetzungen zur verhütung von gefässneubildung und zur behandlung von bösartigen neubildungen
ATE240115T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung der atherosklerose
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
FI971776L (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
EP1582210A3 (de) Mittel und Verfahren zur Behandlung oder Vorbeugung der chirurgischen Adhäsionen
NO952890D0 (no) Kombinasjonsbehandling for inhibisjon av bentap
BR9813228A (pt) Formulação de 2-metil-tieno-benzodiazepina
EE200000741A (et) Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks
IL94990A0 (en) Pharmaceutical compositions for the prophylaxis and/or treatment of prostatic diseases
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DK0679393T3 (da) Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
WO2001030333A3 (en) Tissue factor antagonists and methods of use thereof
DE69935140D1 (de) Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren
ID29547A (id) Metoda dan komposisi untuk pencegahan dan pengobatan tuberkulosis
BR9916432A (pt) Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
DE60142308D1 (de) Vorbeugungs- oder heilmittel gegen endometriose
DE69935976D1 (de) Prävention und therapie von leberzirrhosen
BG102716A (en) Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline
BR0005010A (pt) Composição para tratamento de distúrbios de secreção externa exceto a hipolacrimação e seu uso
WO2001030334A3 (en) 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties